Rothschild Capital Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Rothschild Capital Partners's CELG Position: Q4 2017 in Review
Rothschild Capital Partners sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 47,117 shares — an estimated $6.87M sold.
Rothschild Capital Partners first reported a position in CELG in Q1 2015 and held it in 10 quarters. The position peaked at $6.87M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.
- Rothschild Capital Partners reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
- Rothschild Capital Partners sold 47,117 Celgene Corp shares in Q4 2017, an estimated $6.87M.
- Rothschild Capital Partners first reported a position in Celgene Corp in Q1 2015 and held it in 10 quarters.
- Rothschild Capital Partners's Celgene Corp position peaked at $6.87M in Q3 2017.
- 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.
Based on Rothschild Capital Partners's 13F filing for Q4 2017, filed 31 Jan 2018.